To Asses efficacy and safety of polyherbal unani formulation In Nazla

Evaluation of efficacy and safety of polyherbal unani formulation in Nazla Haar (Allergic Rhinitis) - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058727

Enrollment

Registered

2023-10-17

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: Decoction or Joshanda of Polyherbal Unani Formulation: Decoction of 3gm of Cydonia oblonga mill.(Bahidana),5 gm of Zizyphus vulgaris lau.(Unnab),6 gm of Cordia latifolia roxb(Sapistan),

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient of any sex 2. Age group between 19 to 50 years 3. Patients clinically diagnosed with Nazla Haar(Allergic Rhinitis). 4. Patients with raised Total Eosinophil Count and Total Serum IgE.

Exclusion criteria

Exclusion criteria: 1. Age below 19 years and above 50 years. 2. Pregnancy and Lactation. 3. Patients with history of Comorbidities like Diabetes and Hypertension, Renal impairment, etc. 4.Patients with other disease of Nose.

Design outcomes

Primary

Measure	Time frame
1.The level of Absolute Eosinophil Count and Non specific Serum IgE will be assessed by analysing the blood samples and result will be subjected to statistical analysis using paired t test. 2.The Total Nasal Symptoms Score (TNSS) will be used to assess the sum of score of the following symptoms, Nasal Congestion, Sneezing, Nasal itching, and Rhinorhoea at each time point, using four point scale (0-3).Timepoint: Baseline, 1 and 2 weeks	—

Measure

Time frame

1.The level of Absolute Eosinophil Count and Non specific Serum IgE will be assessed by analysing the blood samples and result will be subjected to statistical analysis using paired t test. 2.The Total Nasal Symptoms Score (TNSS) will be used to assess the sum of score of the following symptoms, Nasal Congestion, Sneezing, Nasal itching, and Rhinorhoea at each time point, using four point scale (0-3).Timepoint: Baseline, 1 and 2 weeks

—

Secondary

Measure	Time frame
Other Allergic disorders like skin allergy may be assessedTimepoint: 0 and 3 weeks	—

Countries

India

Contacts

Public ContactDr Usamah Ahmad

State Unani Medical College

asifhussainusmani@gmail.com7905831926

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026